REGENXBIO INC (RGNX:NASDAQ)
$7.94 -0.005 (-0.0629%)
Analysed REGENXBIO INC (RGNX:NASDAQ) News Sources
REGENXBIO Announces Regulatory Update on RGX-121 for MPS II
24-08-2026
yahoo.com
Safety concerns spur FDA to again halt testing of Regenxbio gene therapy
24-08-2026
biopharmadive.com
REGENXBIO Shares Plunge After FDA Places Clinical Hold on RGX-121
24-08-2026
advfn.com
Why Did RGNX Stock Crash Today?
24-08-2026
stocktwits.com
Why Regenxbio Halted Its Gene Therapy Trial—and Why the Stock Is Tumbling
24-08-2026
yahoo.com
RGNX Stock On Track For Worst Day In Over Three Months — BofA Says Buy Despite ‘Disappointing’ FDA Hold On Gene Therapy
24-08-2026
stocktwits.com
Regenxbio’s RGX-121 Setback Carries A Potential Cash Risk, Warns Clear Street
25-08-2026
stocktwits.com
REGENXBIO Strengthens Board of Directors with Appointment of Greg Ciongoli
25-08-2026
yahoo.com
Regenxbio’s Gene Therapy Faces Another FDA Setback in Hunter Syndrome
05-09-2026
yahoo.com
REGENXBIO to Participate in Upcoming Investor Conferences
08-09-2026
yahoo.com
What is the current price of REGENXBIO INC (RGNX:NASDAQ)?
The current price of REGENXBIO INC (RGNX:NASDAQ) is $7.94.
REGENXBIO INC (RGNX:NASDAQ) absolute price change since previous trading day?
The absolute price change of REGENXBIO INC (RGNX:NASDAQ) since the previous trading day is $-0.005.
REGENXBIO INC (RGNX:NASDAQ) percentage price change since previous trading day?
The percentage price change of REGENXBIO INC (RGNX:NASDAQ) since the previous trading day is -0.0629%.
What is the most recent average sentiment score for REGENXBIO INC (RGNX:NASDAQ)?
The most recent average sentiment score for REGENXBIO INC (RGNX:NASDAQ) is 34 out of 100.
What is the most recent average sentiment for REGENXBIO INC (RGNX:NASDAQ)?
The most recent sentiment for REGENXBIO INC (RGNX:NASDAQ) is .
SEC-8K** Filing Available For REGENXBIO INC (RGNX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.